NKGen Biotech

NKGen Biotech EBITDA per Share

The EBITDA per Share of NKGen Biotech (NKGN) as of Oct 9, 2026 is -0.94 USD. In the previous year, EBITDA per Share was -3.76 USD — a change of -75.09% (higher).

EBITDA per Share

-0.94USD

YoY

-75.09%

Last updated:

EBITDA per Share of NKGen Biotech is 2025 -0.94 USD. EBITDA per Share of NKGen Biotech was 2024 -3.76 USD. It decreases by -75.09% higher compared to the previous year.

The NKGen Biotech EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
0.00 USD
Jan 1, 2021
-1.02 USD
Jan 1, 2022
-1.14 USD
Jan 1, 2023
-3.76 USD
Jan 1, 2025
-0.94 USD
The NKGen Biotech EBITDA per Share history
YEAREBITDA per ShareYoY
-0.94USD-75.09%
-3.76USD+229.61%
-1.14USD+11.37%
-1.02USD—
0.00USD—
Access this data via the Eulerpool API
Get Free API Key

NKGen Biotech Stock analysis

What does NKGen Biotech do? NKGen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NKGen Biotech stock

EBITDA per Share of NKGen Biotech is -0.94 USD in 2025.

EBITDA per Share of NKGen Biotech changed from -3.76 USD to -0.94 USD, representing a -75.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share NKGen Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — NKGen Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — NKGen Biotech